Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Exercise/Conversion of 400 REGN shares, $287.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 400 | $287.7K |
| Aug 12, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 400 | $287.7K |
| Jan 6, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 155 | n/a |
| Jan 6, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 166 | n/a |
| Jan 4, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 42 | n/a |
| Sep 12, 2023 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 240 | n/a |